Pay in 4 interest-free payments of $5.25 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Reduced risk of heart disease: By supporting weight loss and improving cardiovascular markers, semaglutide can lower risk factors associated with heart disease, including inflammation and poor cholesterol balance
Improvement in fibrosis by 1 stage, without worsening of steatohepatitis, occurred in approximately one-third of semaglutide-treated patients, compared with approximately one-fifth of those receiving placebo, corresponding to an absolute difference of 12-15 percentage points and an NNT of ~6-8
WHAT ARE GLP-1 INJECTIONS
[1] [3] It belongs to a class of medicines called glucagon-like peptide-1 (GLP-1) receptor agonists, originally developed for type 2 diabetes management but now used for chronic weight management following NICE guidance and MHRA approval
The table below sets out the key differences so you can see which format fits your lifestyle and treatment goals
US$ 26.00
US$ 21.25
US$ 29.30
US$ 29.95
US$ 26.25
